Literature DB >> 11078210

Proteasome expression in the skeletal muscles of patients with muscular dystrophy.

T Kumamoto1, S Fujimoto, T Ito, H Horinouchi, H Ueyama, T Tsuda.   

Abstract

Previous investigators have suggested that proteolysis by calpain, a Ca2+-dependent protease, causes muscle fiber degradation in Duchenne and Becker muscular dystrophies (DMD/BMD). Recent evidence indicates that the nonlysosomal ATP-ubiquitin-dependent proteolytic complex (proteasomes) participates in muscle wasting during various catabolic states and in muscle fiber degradation in physiological or pathological conditions. To elucidate the possible role of proteasomes in dystrophic muscles, routine histochemistry and immunohistochemistry of 26S proteasomes were performed on muscle biopsy specimens obtained from patients with various neuromuscular disorders including DMD/BMD, polymyositis (PM), amyotrophic lateral sclerosis, and peripheral neuropathies, and on normal human muscle specimens. Immunohistochemically, proteasomes were located in the cytoplasm in normal human muscle, but their staining intensity was faint. Compared to control muscles, abnormal increases in both proteasomes and ubiquitin were demonstrated mainly in the cytoplasm of necrotic fibers and to a lesser extent in regenerative fibers in DMD/BMD and PM. Non-necrotic, atrophic fibers in all diseased muscles showed moderate or weak immunoreactions for the proteins; their staining intensities were stronger than those of control muscle fibers. Both proteins often colocalized well. Not all dystrophin-deficient muscle fibers showed a strong reaction for proteasomes. Our results showed increased proteasomes in necrotic and regenerative muscle fibers in DMD/ PMD, although this may not be disease-specific up-regulation. We suggest that the ATP-ubiquitin-dependent proteolytic pathway as well as the nonlysosomal calpain pathway may participate in muscle fiber degradation in muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11078210     DOI: 10.1007/s004010000229

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  21 in total

1.  Alterations in mRNA expression and protein products following spinal cord injury in humans.

Authors:  Maria L Urso; Yi-Wen Chen; Angus G Scrimgeour; Patrick C Lee; K Francis Lee; Priscilla M Clarkson
Journal:  J Physiol       Date:  2007-01-11       Impact factor: 5.182

Review 2.  Degradation of oxidized proteins by the proteasome: Distinguishing between the 20S, 26S, and immunoproteasome proteolytic pathways.

Authors:  Rachel Raynes; Laura C D Pomatto; Kelvin J A Davies
Journal:  Mol Aspects Med       Date:  2016-05-04

3.  Regulation of the calpain and ubiquitin-proteasome systems in a canine model of muscular dystrophy.

Authors:  Kristine M Wadosky; Luge Li; Jessica E Rodríguez; Jin-Na Min; Dan Bogan; Jason Gonzalez; Cam Patterson; Joe N Kornegay; Monte Willis
Journal:  Muscle Nerve       Date:  2011-08-08       Impact factor: 3.217

4.  Discovery of putative oocyte quality markers by comparative ExacTag proteomics.

Authors:  Michael D Powell; Gaurishankar Manandhar; Lee Spate; Miriam Sutovsky; Shawn Zimmerman; Shrikesh C Sachdev; Mark Hannink; Randall S Prather; Peter Sutovsky
Journal:  Proteomics Clin Appl       Date:  2010-01-04       Impact factor: 3.494

5.  Therapeutic potential of proteasome inhibition in Duchenne and Becker muscular dystrophies.

Authors:  Elisabetta Gazzerro; Stefania Assereto; Andrea Bonetto; Federica Sotgia; Sonia Scarfì; Angela Pistorio; Gloria Bonuccelli; Michele Cilli; Claudio Bruno; Federico Zara; Michael P Lisanti; Carlo Minetti
Journal:  Am J Pathol       Date:  2010-03-19       Impact factor: 4.307

6.  Immunoproteasome in animal models of Duchenne muscular dystrophy.

Authors:  Chiao-Nan Joyce Chen; Ted G Graber; Wendy M Bratten; Deborah A Ferrington; LaDora V Thompson
Journal:  J Muscle Res Cell Motil       Date:  2014-06-17       Impact factor: 2.698

7.  Adeno-associated virus serotype 8 (AAV8) delivery of recombinant A20 to skeletal muscle reduces pathological activation of nuclear factor (NF)-κB in muscle of mdx mice.

Authors:  Rakshita A Charan; Gabriela Niizawa; Hiroyuki Nakai; Paula R Clemens
Journal:  Mol Med       Date:  2013-02-08       Impact factor: 6.354

8.  Therapeutic Potential of Immunoproteasome Inhibition in Duchenne Muscular Dystrophy.

Authors:  Andrea Farini; Clementina Sitzia; Barbara Cassani; Letizia Cassinelli; Rosita Rigoni; Federica Colleoni; Nicola Fusco; Stefano Gatti; Pamela Bella; Chiara Villa; Filomena Napolitano; Rita Maiavacca; Silvano Bosari; Anna Villa; Yvan Torrente
Journal:  Mol Ther       Date:  2016-08-10       Impact factor: 11.454

9.  Inhibition of proteasome activity promotes the correct localization of disease-causing alpha-sarcoglycan mutants in HEK-293 cells constitutively expressing beta-, gamma-, and delta-sarcoglycan.

Authors:  Stefano Gastaldello; Simona D'Angelo; Susanna Franzoso; Marina Fanin; Corrado Angelini; Romeo Betto; Dorianna Sandonà
Journal:  Am J Pathol       Date:  2008-06-05       Impact factor: 4.307

10.  Severe burn increased skeletal muscle loss in mdx mutant mice.

Authors:  Melody R Saeman; Kevin DeSpain; Ming-Mei Liu; Steven E Wolf; Juquan Song
Journal:  J Surg Res       Date:  2016-03-04       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.